Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Completed

A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

NCT04131309

Conditions
Amyloidosis, Light Chain (AL) Amyloidosis, Stage 3B, Metabolic Diseases, +2 more
Locations
  • Hopitaux Universitaires Henri-Mondor Créteil, France
  • Hopital De Rangueil CHU Toulouse, France
  • National and Kapodistrian University of Athens, School of Medicine Athens, Greece
  • University Hospital San Matteo Pavia, Italy
View Trial Details
Completed

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

NCT03548311

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Miyoshi Neurological Clinic Miyoshi, Hiroshima, Japan
  • Sapporo Medical University Hospital Sapporo, Hokkaido, Japan
  • Kobe Central Munincipal Medical center Kobe, Hyōgo, Japan
View all 16 locations
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis

NCT05178810

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University Hospitals Leuven Leuven, Belgium
  • CHRU de Lille - Hôpital Roger Salengro Lille, France
  • CHU de Limoges - Hôpital Dupuytren Limoges, France
  • Centre Hospitalo-Universitaire La Timone Marseille, France
View all 38 locations
View Trial Details
Completed

Ixazomib Rollover Study

NCT02924272

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Appalachian Regional Healthcare Hazard, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 26 locations
View Trial Details

Related conditions